Since its inception in 2016, the fund has achieved the following 
  • 53% of eligible Quad faculty applied
  • Reviewed 216 grant proposals
  • Q-FASTR awardees had 5 new start-up companies and close to $185 million in follow-on funding, which corresponds to 12.3 times our investment

2025 Awardees

Congratulations to the following award recipients of this year's Q-FASTR RFP:

  • Bruce Bean (Harvard Medical School)
  • Isaac Chiu (Harvard Medical School) and Alexander Horswill (University of Colorado)
  • David Corey (Harvard Medical School) and Olga Shubina-Oleinik (Harvard Medical School)
  • Josefina del Marmol (Harvard Medical School)
  • Ruth Franklin (Harvard University/Harvard Medical School)
  • Andrew Kruse (Harvard Medical School) and Jeffrey Smith (Harvard Medical School)
  • Norbert Perrimon (Harvard Medical School)
  • Lee Rubin (Harvard Medical School) and Karen Adelman (Harvard Medical School)
  • Bernardo Sabatini (Harvard Medical School) and Daniel Hochbaum (Harvard Medical School)
  • Arlene Sharpe (Harvard Medical School) and Eric Smith (Dana-Farber Cancer Institute)
  • Pamela Silver (Harvard Medical School), Michael Springer (Harvard Medical School) and Neil Dalvie (Harvard Medical School)
  • Ulrich von Andrian (Harvard Medical School)

For more details about their research, please visit the Projects section.

Q-FASTR Projects
2025 Q-FASTR Open House & Innovation Showcase

Q-FASTR is dedicated to transforming cutting-edge basic research at HMS into tomorrow’s therapeutics, diagnostics, and related technologies. By championing early ideas and enveloping them with financial and scientific support, we cultivate breakthroughs that have the potential to reshape medicine.

Ifat Rubin-Bejerano
Senior Director, Translational Research Programs, Harvard Medical School